India's Ongoing Battle Against Tuberculosis: Challenges and Progress

The Stigma and Spread of TB in India

• 😔 Tuberculosis (TB) remains highly stigmatized in India, leading many to fear ostracization and refuse medical advice, making it difficult for health counselors to reach patients.
• 🏘️ Overcrowding in urban slums, like those in Mumbai, significantly increases the chances of disease spreading within families due to poor ventilation and close living conditions.
• 📊 In 2023, India accounted for one-third of the world's 10.8 million new TB cases, with approximately 400,000 deaths, highlighting the scale of the epidemic.

Technological Advancements in TB Detection

• 🔬 Advanced technologies like next-gen sequencing are revolutionizing TB detection, enabling DNA analysis in just 3 days to identify resistance to all 14 available drugs.
• 🎯 This technology acts as a bridge to precision therapy, allowing doctors to provide targeted treatments and avoid ineffective drugs for patients.
• 💰 Despite its efficiency, the high cost of advanced diagnostic technology limits its accessibility in India.

The Challenge of Multi-Drug Resistant TB (MDR-TB)

• ⚠️ Over 60,000 MDR-TB cases were reported in India in 2023, driven by inadequate treatment or patients dropping out due to severe side effects.
• 🧬 When TB treatment is insufficient, residual germs can mutate, leading to the evolution of multi-drug-resistant tuberculosis.
• 👂 MDR-TB can cause severe bodily damage, as seen in a patient who suffered 90% hearing loss due to medication side effects, even after successful treatment.

Progress Towards Treatment and Eradication

• 💊 The drug Bedaquiline, once patented by Johnson & Johnson, is now being produced more affordably in India, offering a replacement for toxic older medications.
• ✅ In 2024, Bedaquiline was finally introduced by the Indian government as a new regimen to cure TB, marking a significant step in the country's long journey.
• ⚖️ TB survivors have actively challenged drug patents, enabling more affordable access to crucial TB medications for a wider population.